Circulating SH2B1 is associated with an increased risk of gastric cancer

Liu,Bo; Li,Feng; Zhao,Hong‑Peng; Chen,Jing‑Bo; Li,Yu‑Peng; Yu,Hai‑Hua

doi:10.3892/ol.2018.8196

Circulating SH2B1 is associated with an increased risk of gastric cancer

Authors:
- Bo Liu
- Feng Li
- Hong‑Peng Zhao
- Jing‑Bo Chen
- Yu‑Peng Li
- Hai‑Hua Yu
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China
Published online on: March 7, 2018 https://doi.org/10.3892/ol.2018.8196
Pages: 7305-7311

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) is one of the most common types of cancer in humans and the second leading cause of cancer-associated mortality worldwide. Identifying novel risk factors will facilitate the development of therapeutic strategies to prevent and treat GC. Increased expression of the Src homology 2 B adaptor protein 1 (SH2B1) may stimulate the malignant progression of lung cancer, esophageal cancer and neuroblastoma. However, its function in GC has not yet been investigated. To identify whether increased serum SH2B1 is a risk factor for GC, the present study performed a nested case‑control study of patients within the Chinese cohort study. Levels of serum SH2B1 were measured in 563 patients diagnosed with GC during the follow‑up period and in 1,126 matched healthy controls. The results demonstrated that high levels of serum SH2B1 were associated with an increased GC risk (odds ratio, 3.23; 95% confidence interval, 2.45‑5.65). When analyses were stratified further by sex, age and smoking, an association between increased levels of SH2B1 and GC was identified in males but not in females. Furthermore, the association between SH2B1 levels and GC was more evident in younger than in older participants, and statistically significant in current smokers but not in nonsmokers. These results were not altered following the exclusion of outliers. Furthermore, it was demonstrated that overexpression of SH2B1 contributes to the malignant transformation of normal gastric epithelial cells. Thus, the present study demonstrated that elevated serum SH2B1 levels may increase the risk of GC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, et al: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
3	Zhao P, Dai M, Chen W and Li N: Cancer trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
4	Axon A: Symptoms and diagnosis of gastric cancer at early curable stage. Best Pract Res Clin Gastroenterol. 20:697–708. 2006. View Article : Google Scholar : PubMed/NCBI
5	Chen CN, Lin JJ, Chen JJ, Lee PH, Yang CY, Kuo ML, Chang KJ and Hsieh FJ: Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol. 23:7286–7295. 2005. View Article : Google Scholar : PubMed/NCBI
6	Song W, Ren D, Li W, Jiang L, Cho KW, Huang P, Fan C, Song Y, Liu Y and Rui L: SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab. 11:427–437. 2010. View Article : Google Scholar : PubMed/NCBI
7	Ren D, Zhou Y, Morris D, Li M, Li Z and Rui L: Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest. 117:397–406. 2007. View Article : Google Scholar : PubMed/NCBI
8	Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD and Zhang CF: Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer. Asian Pac J Cancer Prev. 13:2355–2362. 2012. View Article : Google Scholar : PubMed/NCBI
9	Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res. 35:762016. View Article : Google Scholar : PubMed/NCBI
10	Javadi M, Hofstätter E, Stickle N, Beattie BK, Jaster R, Carter-Su C and Barber DL: The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor. J Biol Chem. 287:26223–26234. 2012. View Article : Google Scholar : PubMed/NCBI
11	Zhang H, Duan C, Zhang H, Cheng Y and Zhang C: Expression of SH2B1 adaptor protein in oesophageal cancer and its clinical significance. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 38:125–131. 2013.(in Chinese). PubMed/NCBI
12	Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD and Zhang CF: Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer. Asian Pac J Cancer Prev. 13:2355–2362. 2012. View Article : Google Scholar : PubMed/NCBI
13	Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao YL and Taylor PR: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 113:456–463. 2005. View Article : Google Scholar : PubMed/NCBI
14	Gehrmann M, Cervello M, Montalto G, Cappello F, Gulino A, Knape C, Specht HM and Multhoff G: Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol. 5:3072014. View Article : Google Scholar : PubMed/NCBI
15	Shang Z, Cai Q, Zhang M, Zhu S, Ma Y, Sun L, Jiang N, Tian J, Niu X, Chen J, et al: A switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer. Oncotarget. 6:1202–1216. 2015. View Article : Google Scholar : PubMed/NCBI
16	Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates proliferation of breast cancer MCF–7 cells via a p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014. View Article : Google Scholar : PubMed/NCBI
17	Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C and Speizer FE: Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period. Cancer Epidemiol Biomarkers Prev. 4:649–654. 1995.PubMed/NCBI
18	Lu D, Sookthai D, Le Cornet C, Katzke VA, Johnson TS, Kaaks R and Fortner RT: Reproducibility of serum oxysterols and lanosterol among postmenopausal women: Results from EPIC-Heidelberg. Clin Biochem. 2017.(Epub ahead of print).
19	Rosner B, Spiegelman D and Willett W: Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol. 136:1400–1413. 1992. View Article : Google Scholar : PubMed/NCBI
20	Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, Franke AA, Mantzoros CS, Ricchiuti V, Willett WC, Hankinson SE and Eliassen AH: Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 19:938–946. 2010. View Article : Google Scholar : PubMed/NCBI
21	Trédaniel J, Boffetta P, Buiatti E, Saracci R and Hirsch A: Tobacco smoking and gastric cancer: Review and meta-analysis. Int J Cancer. 72:565–573. 1997. View Article : Google Scholar : PubMed/NCBI
22	Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M and Giraud AS: STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology. 131:1073–1085. 2006. View Article : Google Scholar : PubMed/NCBI
23	Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
24	Xu AG, Li SG, Liu JH and Gan AH: Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol. 7:403–406. 2001. View Article : Google Scholar : PubMed/NCBI
25	Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, et al: miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clin Cancer Res. 20:4636–4646. 2014. View Article : Google Scholar : PubMed/NCBI
26	Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F and Esteller M: Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene. 31:2062–2074. 2012. View Article : Google Scholar : PubMed/NCBI